Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9063 USD | +2.99% | -4.19% | +4.45% |
Business Summary
Number of employees: 14
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Novel Therapies
100.0
%
| 1 | 100.0 % | 1 | 100.0 % | -29.02% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 1 | 100.0 % | 1 | 100.0 % | -29.02% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Shalabh Gupta
CEO | Chief Executive Officer | 51 | 16-08-17 |
John Townsend
DFI | Director of Finance/CFO | 62 | 20-08-31 |
Pramod Gupta
COO | Chief Operating Officer | 63 | 20-08-31 |
Douglas Jermasek
PRN | Corporate Officer/Principal | 63 | 21-10-25 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Sandeep Laumas
BRD | Director/Board Member | 56 | 17-12-31 |
John Ryan
BRD | Director/Board Member | 80 | 17-12-31 |
Gaurav Aggarwal
BRD | Director/Board Member | 51 | 23-03-07 |
Director/Board Member | 56 | 23-09-05 | |
Shalabh Gupta
CEO | Chief Executive Officer | 51 | 16-08-17 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 37,606,630 | 31,252,357 ( 83.10 %) | 0 | 83.10 % |
Stock B | 0 | 43,649 | 0 | 0 |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.45% | 34.08M | |
+48.64% | 56.65B | |
-6.44% | 39.44B | |
+36.92% | 39.03B | |
+14.28% | 26.75B | |
-11.17% | 26.86B | |
-21.40% | 19.03B | |
+25.64% | 12.26B | |
+0.96% | 12.28B | |
+27.04% | 12.04B |
- Stock Market
- Equities
- UNCY Stock
- Company Unicycive Therapeutics, Inc.